Navigation Links
Jury Rules in Favor of Glycoproducts International, Inc.
Date:5/28/2008

RIGGINS, Idaho, May 28 /PRNewswire/ -- Glycoproducts International, Inc., a provider of nutritional supplement products, today announced that a federal court jury sitting in the Northern District of Texas returned a mixed verdict relating to claims that Glycoproducts International, Inc. committed patent infringement of two of Mannatech, Incorporated's (Nasdaq: MTEX) patents relating to Mannatech's AMBROTOSE(R) technology.

The jury ruled in favor of Glycoproducts International, Inc., finding that they were innocent of patent infringement of Mannatech's U.S. Patent No. 6,929,807, the parent patent upon which the lawsuit against Glycoproducts International, Inc. was originally based. However, in regard to Mannatech's continuation patent of the parent patent, U.S. Patent No. 7,157,431, which was issued and first claimed to be infringed by Mannatech after the lawsuit was filed, the jury found that Glycoproducts International, Inc. had committed patent infringement.

The jury ruled in favor of Mannatech on its claims of infringement of the AMBROTOSE(R) trademark. Since Glycoproducts International, Inc. successfully defended its position against Mannatech's '807' parent patent, it will oppose Mannatech's request for an injunction to prohibit Glycoproducts International, Inc. from further production, distribution and sale of its Glycomannan(R) product.

Phil Moulton, president of Glycoproducts International, Inc. said, "Our product is distinctly different from Mannatech's products, and is a source of at least 10 of the 11 scientifically recognized biologically vital sugars, with minerals, bioflavonoids and other nutrients that naturally occur within the whole-food matrix."

"Our products are derived from natural sources and are not diluted with rice fillers," he stated.

The verdict was delivered on Friday, May 9, 2008, in the United States District Court for the Northern District of Texas, Dallas Division, following testimony before Federal Magistrate Jeff Kaplan. Glycoproducts International, Inc. (formerly Glycobiotics International, Inc.) was represented by Attorney William G. Shaw, Jr., of Collins, Basinger & Pullman, P.C.


'/>"/>
SOURCE Glycoproducts International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Consumer Watchdog Raises Concern That Health Policy Cancellation Rules Have Been Derailed in Deal With Kaiser
2. Oregon Supreme Court Rules in Favor of R.J. Reynolds Tobacco Company in Medical Monitoring Suit
3. Virginia Judge Rules Medical Device Pioneer Committed Malpractice
4. DARA Announces Information in Compliance with NASDAQ Rules
5. MedApps Wins Nokia 2008 Mobile Rules! Business Plan Competition Award
6. MedCom Announces Court Rules Card Activation Technologies Patent Is Valid
7. VIDEO from Medialink and The Childrens Hospital of Philadelphia: New Research - Rules of the Road for Teens and Passengers
8. When the rules of the game are broken: Research studies sports injuries related to illegal activity
9. IHF Says Google Personal Health-Records System Gives Consumers Greater Control Over Privacy than HIPAA Rules
10. Aetna Requires CAQH Core Rules Certification for Vendors
11. CAQH Core Rules Final Component of HITSP Interoperability Standards Formally Recognized By HHS Sec. Leavitt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine ... Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC ... by obtaining investment capital for emerging technology companies. SCP has delivered investment ... resulted in more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... human induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces ... Medium. The PluriQ™ G9™ Gene Editing System is a complete system ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... today announced the appointment of Dr. Edward ... as a Non-Executive Director, effective June 23, 2016.Dr. ... Compensation and Nominations and Governance Committees.  As a ... will provide independent expertise and strategic counsel to ...
Breaking Medicine Technology: